Comparative field study evaluating the activity of recombinant Factor IX - Fc fusion protein (rFIXFc) in plasma samples at clinical haemostasis laboratories

被引：0
|
作者：
Sommer, J. [1 ]
Buyue, Y. [1 ]
Peters, R. T. [1 ]
Jiang, H. [1 ]
Gray, E. [2 ]
Pierce, G. F. [1 ]
机构：
[1] Biogen Idec Hemophilia, Waltham, MA USA
[2] NIBSC, Potters Bar, Herts, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：828 / 829
页数：2
相关论文
共 50 条
  • [21] FACTOR CONSUMPTION FOR PROPHYLAXIS AND TREATMENT OF BLEEDING: RECOMBINANT FACTOR IX FC FUSION PROTEIN COMPARED WITH CONVENTIONAL RECOMBINANT FACTOR IX
    Iorio, A.
    Krishnan, S.
    Myren, K.
    Lethagen, S.
    McCormick, N.
    Kamer, P.
    VALUE IN HEALTH, 2015, 18 (07) : A660 - A660
  • [22] Clinical Outcomes in Children with Haemophilia B Treated Long Term with Recombinant Factor IX FC Fusion Protein (rFIXFc) Prophylaxis: Interim Results of the B-YOND Extension Study
    Fischer, K.
    Kulkarni, R.
    Nolan, B.
    Bennett, C. M.
    Perry, D. J.
    Barnes, C.
    Yuan, H.
    Ramirez-Santiago, A.
    Pierce, G. F.
    Mei, B.
    HAEMOPHILIA, 2016, 22 : 47 - 48
  • [23] Prolonged activity of factor IX as a monomeric Fc fusion protein
    Peters, Robert T.
    Low, Susan C.
    Kamphaus, George D.
    Dumont, Jennifer A.
    Amari, John V.
    Lu, Qi
    Zarbis-Papastoitsis, Greg
    Reidy, Thomas J.
    Merricks, Elizabeth P.
    Nichols, Timothy C.
    Bitonti, Alan J.
    BLOOD, 2010, 115 (10) : 2057 - 2064
  • [24] International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories
    St Ledger, K.
    Feussner, A.
    Kalina, U.
    Horn, C.
    Metzner, H. J.
    Bensen-Kennedy, D.
    Blackman, N.
    Veldman, A.
    Stowers, A.
    Friedman, K. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (03) : 555 - 564
  • [25] Population pharmacokinetic analysis of a long-acting recombinant factor IX-FC fusion protein (RFIXFC) in patients with severe haemophilia B
    Diao, L.
    Li, S.
    Nestorov, I.
    Jiang, H.
    HAEMOPHILIA, 2013, 19 : 33 - 33
  • [26] Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B
    Pasi, K. John
    Fischer, Kathelijn
    Ragni, Margaret
    Nolan, Beatrice
    Perry, David J.
    Kulkarni, Roshni
    Ozelo, Margareth
    Mahlangu, Johnny
    Shapiro, Amy D.
    Baker, Ross I.
    Bennett, Carolyn M.
    Barnes, Christopher
    Oldenburg, Johannes
    Matsushita, Tadashi
    Yuan, Huixing
    Ramirez-Santiago, Alejandra
    Pierce, Glenn F.
    Allen, Geoffrey
    Mei, Baisong
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (03) : 508 - 518
  • [27] Real-world outcomes with recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis: Longitudinal follow-up in a national adult cohort
    O'Donovan, Mairead
    Bergin, Catherine
    Quinn, Eimear
    Singleton, Evelyn
    Roche, Sheila
    Benson, Julie
    Bird, Rachel
    Byrne, Mary
    Duggan, Cleona
    Gilmore, Ruth
    Ryan, Kevin
    O'Donnell, James S.
    O'Connell, Niamh M.
    HAEMOPHILIA, 2021, 27 (04) : 618 - 625
  • [28] Individualised Prophylaxis with Recombinant Factor IX FC Fusion Protein (RFIXFC) in Adults/Adolescents With Haemophilia B: Updated Interim Results of the B-YOND Extension Study
    Mahlangu, J. N.
    Shapiro, A. D.
    Pasi, K. J.
    Ragni, M. V.
    Ozelo, M. C.
    Oldenburg, J.
    Matsushita, T.
    Baker, R. I.
    Yuan, H.
    Ferrante, F.
    Ramirez-Santiago, A.
    Lethagen, S.
    Barnowski, C.
    HAEMOPHILIA, 2017, 23 : 85 - 86
  • [29] Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study
    Powell, Jerry S.
    Apte, Shashikant
    Chambost, Herve
    Hermans, Cedric
    Jackson, Shannon
    Josephson, Neil C.
    Mahlangu, Johnny N.
    Ozelo, Margareth C.
    Peerlinck, Kathelijne
    Pasi, John
    Perry, David
    Ragni, Margaret V.
    Wang, Xuefeng
    Jiang, Haiyan
    Li, Shuanglian
    Cristiano, Lynda M.
    Innes, Alison
    Nugent, Karen
    Brennan, Aoife
    Luk, Alvin
    Allen, Geoffrey
    Pierce, Glenn F.
    Robinson, Brian
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (01) : 124 - 134
  • [30] B-LONG: results from a Phase 3 study of safety, efficacy, and pharmacokinetics of long-lasting recombinant factor IX Fc Fusion Protein (rFIXFc)
    Powell, J.
    Ozelo, M. C.
    Pasi, J.
    Ragni, M.
    Valentino, L. A.
    Mahlangu, J.
    Manco-Johnson, M.
    Josephson, N.
    Perry, D.
    Pierce, G. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 240 - 240
12345